110 related articles for article (PubMed ID: 32913402)
1. 20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway.
Xia T; Zhang J; Zhou C; Li Y; Duan W; Zhang B; Wang M; Fang J
J Ginseng Res; 2020 Sep; 44(5):725-737. PubMed ID: 32913402
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway.
Huang Y; Wu S; Zhang Y; Wang L; Guo Y
Onco Targets Ther; 2018; 11():769-779. PubMed ID: 29483777
[TBL] [Abstract][Full Text] [Related]
3. Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia
Ge C; Zhang J; Feng F
RSC Adv; 2019 Aug; 9(43):25022-25033. PubMed ID: 35528698
[TBL] [Abstract][Full Text] [Related]
4. 20(S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3.
Cheng S; Chen L; Ying J; Wang Y; Jiang W; Zhang Q; Zhang H; Wang J; Wang C; Wu H; Ye J; Zhang L
J Ginseng Res; 2024 May; 48(3):298-309. PubMed ID: 38707638
[TBL] [Abstract][Full Text] [Related]
5. Gypenoside induces apoptosis by inhibiting the PI3K/AKT/mTOR pathway and enhances T-cell antitumor immunity by inhibiting PD-L1 in gastric cancer.
Wu H; Lai W; Wang Q; Zhou Q; Zhang R; Zhao Y
Front Pharmacol; 2024; 15():1243353. PubMed ID: 38482051
[No Abstract] [Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment of triple negative breast cancer by suppressing PI3K/AKT/mTOR pathway.
Qin J; Sun X; Ma Y; Cheng Y; Ma Q; Jing W; Qu S; Liu L
Bioorg Med Chem; 2022 Feb; 55():116594. PubMed ID: 34990979
[TBL] [Abstract][Full Text] [Related]
7. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
Cardoso BA; Duque M; Gírio A; Fragoso R; Oliveira ML; Allen JR; Martins LR; Correia NC; Silveira AB; Veloso A; Kimura S; Demoen L; Matthijssens F; Jeha S; Cheng C; Pui CH; Grosso AR; Neto JL; De Almeida SF; Van Vlieberghe P; Mullighan CG; Yunes JA; Langenau DM; Pflumio F; Barata JT
Haematologica; 2023 Dec; 109(6):1713-25. PubMed ID: 38058200
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway.
Jia Y; Qi Y; Wang Y; Ma X; Xu Y; Wang J; Zhang X; Gao M; Cong B; Han S
Cancer Cell Int; 2019; 19():9. PubMed ID: 30636930
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mTOR pathway.
Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activities of natural abietic acid.
Ahmad B; Tian C; Tang JX; Dumbuya JS; Li W; Lu J
Front Pharmacol; 2024; 15():1392203. PubMed ID: 38633616
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Effect of Triptolide in T-Cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial-Mesenchymal Transition via Regulating the PI3K/AKT/mTOR Pathway [Retraction].
Onco Targets Ther; 2024; 17():303-304. PubMed ID: 38595926
[TBL] [Abstract][Full Text] [Related]
12. Retraction notice to "Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis" [Biomed. Pharmacother. 102 (2018) 1209-1220].
Feng FB; Qiu HY
Biomed Pharmacother; 2023 Jun; 162():114550. PubMed ID: 36967365
[No Abstract] [Full Text] [Related]
13. Differential activation of basal and IL-7-induced PI3K/Akt/mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.
Fernandes MB; Gomes AM; Oliveira ML; Caldas J; Lúcio P; Kim R; Caye-Eude A; Pereira F; De Sousa AB; De Stefano A; Follo MY; Soares MV; Lacerda JF; Desterro J; Cavé H; Clappier E; Duarte X; Ribeiro P; Barata JT
Haematologica; 2024 Apr; ():. PubMed ID: 38654666
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to "Chondroprotective effects of Apolipoprotein D in knee osteoarthritis mice through the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 133 (2024) 112005].
Zhang G; Huang C; Wang R; Guo J; Qin Y; Lv S
Int Immunopharmacol; 2024 Jun; 134():112220. PubMed ID: 38734566
[No Abstract] [Full Text] [Related]
15. Erratum: CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.
He Z; Shen S; Yi Y; Ren L; Tao H; Wang F; Jia Y
Am J Transl Res; 2024; 16(3):1036. PubMed ID: 38586108
[TBL] [Abstract][Full Text] [Related]
16. Effects of red ginseng on the elastic properties of human skin.
Park MY; Han SJ; Moon D; Kwon S; Lee JW; Kim KS
J Ginseng Res; 2020 Sep; 44(5):738-746. PubMed ID: 32913403
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 represses autophagy to promote cervical cancer cell apoptosis during starvation.
Wang J; Bian S; Wang S; Yang S; Zhang W; Zhao D; Liu M; Bai X
Chin Med; 2020 Nov; 15(1):118. PubMed ID: 33292331
[TBL] [Abstract][Full Text] [Related]
18. Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine.
Chen Y; Fan W; Zhao Y; Liu M; Hu L; Zhang W
Molecules; 2024 May; 29(10):. PubMed ID: 38792234
[TBL] [Abstract][Full Text] [Related]
19. Anti-leukemia effects of ginsenoside monomer: A narrative review of pharmacodynamics study.
Dana SMMA; Meghdadi M; Kakhki SK; Khademi R
Curr Ther Res Clin Exp; 2024; 100():100739. PubMed ID: 38706463
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
